Merck & Company Inc - Cost of Goods Sold Including Depreciation and Amortization

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 13.93 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2022.

Merck & Company Inc's third quarter result of 3.12 Billion USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -12.17 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 3.12 Billion USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -23.43 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 13.93 Billion USD for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -6.42 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -8.83 percent compared to the value the year prior.
The 1 year change in percent is -8.83.
The 3 year change in percent is -19.97.
The 5 year change in percent is 9.32.
The 10 year change in percent is -6.10.

The Serie's long term average value is 15.16 Billion United States Dollars. It's latest available value, on 09/30/2025, is 8.10 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2020, to it's latest available value, on 09/30/2025, is +9.32%.
The Serie's change in percent from it's maximum value, on 09/30/2014, to it's latest available value, on 09/30/2025, is -20.98%.